BrightSpring Health Services, Inc. BTSG
56.59
0.57
1.02%
as of 25 Sep
- Market cap
- $11.1B
- P/E
- 31.6×
Follow BTSG
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 39.84 |
P/S ratio |
0.15 | 0.15 | 0.15 | 0.33 | 0.59 |
P/FCF ratio |
9.45 | 9.45 | 9.45 | 0.00 | 19.22 |
P/Operating CF |
7.98 | 7.98 | 7.98 | 36.27 | 32.76 |
P/B ratio |
2.21 | 2.21 | 2.21 | 1.99 | 4.05 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.53 | 0.53 | 0.53 | 0.58 | 0.78 |
EV/EBITDA |
3.30 | 3.30 | 3.30 | 18.00 | 21.28 |
EV/Operating CF |
22.16 | 22.16 | 22.16 | 245.77 | 20.44 |
EV/FCF |
34.02 | 34.02 | 34.02 | (102.26) | 25.39 |
Quick Ratio |
— | 0.85 | 0.72 | 0.67 | 0.58 |
Current Ratio |
— | 1.44 | 1.17 | 1.33 | 1.57 |
Net Debt/EBITDA |
0.00 | 7.51 | 11.99 | 7.88 | 5.17 |
Debt/Assets |
0.00% | 62.76% | 61.21% | 44.16% | 39.33% |
Debt/Equity |
0.00 | 4.52 | 5.79 | 1.59 | 1.35 |
Asset Turnover |
0.00 | 2.84 | 1.40 | 1.76 | 2.09 |
Operating CF/Net income |
5.43 | 0.09 | (1.36) | (1.32) | 2.57 |
Capex/Depreciation |
(0.27) | (0.26) | (0.33) | (0.37) | (0.54) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | (23.07%) | (1.62%) | 10.82% | |
| 0.00% | (1.98%) | (2.82%) | (0.32%) | 3.09% | |
ROIC |
0.00% | 2.82% | 0.92% | 1.60% | 4.28% |
Return on Tangible Assets |
0.00% | (8.41%) | (34.05%) | (2.80%) | 15.26% |
Average Days of Receivables |
0.00 | 36.68 | 41.84 | 32.72 | 27.98 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
15.14% | 14.58% | 14.05% | 11.50% | 9.47% |
Intangible Assets out of Total Assets |
0.00 | 0.65 | 0.63 | 0.50 | 0.48 |
Share Based Compensation of Revenue |
0.07% | 0.05% | 0.05% | 0.69% | 0.54% |
Graham Net Nets |
(2.69) | (2.69) | (2.69) | (0.73) | (0.22) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 13.99 |
Earnings Yield |
(12.09%) | (12.09%) | (12.09%) | (0.70%) | 2.51% |
Free Cash Flow Yield |
10.59% | 10.59% | 10.59% | (1.74%) | 5.20% |
Revenue per Share |
56.96 | 65.52 | 65.25 | 52.19 | 63.74 |
Operating CF per Share |
2.30 | (0.04) | 1.79 | 0.12 | 2.42 |
Capex per Share |
(0.50) | (0.59) | (0.62) | (0.42) | (0.47) |
Free Cash Flow per Share |
1.79 | (0.63) | 1.16 | (0.30) | 1.95 |
Cash per Share |
0.00 | 0.12 | 0.11 | 0.32 | 0.44 |
Shareholders Equity per Share |
0.00 | 6.41 | 4.97 | 8.54 | 9.26 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 6.41 | 4.97 | 8.54 | 9.26 |
Free Cash Flow |
210.90 | (74.77) | 137.26 | (57.14) | 394.69 |
Working Capital |
— | 411.75 | 208.20 | 464.72 | 1,045.02 |
Capital Expenditures |
(59.27) | (70.11) | (73.53) | (80.91) | (95.48) |
Net Current Asset Value |
0.00 | (3,342.11) | (3,490.67) | (2,385.23) | (1,644.12) |
EV/EBIT |
3.91 | 3.91 | 3.91 | 54.12 | 33.94 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Net Profit Margin |
0.74% | (0.70%) | (2.01%) | (0.18%) | 1.48% |
Price to Operating Income |
1.09 | 1.09 | 1.09 | 30.45 | 25.69 |
| Other line items | |||||
Depreciation/Fixed assets |
0.00 | 1.16 | 0.91 | 1.20 | 0.86 |
Cash ROIC |
0.00% | (5.59%) | (0.88%) | (3.62%) | 6.36% |
Accounts Receivable Turnover |
0.00 | 0.00 | 9.28 | 11.29 | 13.64 |
Accounts Payable Turnover |
0.00 | 0.00 | 11.21 | 11.25 | 10.64 |
Inventory Turnover |
0.00 | 0.00 | 15.73 | 16.95 | 15.70 |
Average Days of Payables |
0.00 | 30.21 | 35.74 | 38.30 | 39.02 |
Days of Inventory on Hand |
0.00 | 24.68 | 22.44 | 26.39 | 26.12 |
Average Receivables |
— | — | 828.74 | 892.20 | 946.25 |
Average Payables |
— | — | 584.26 | 782.77 | 1,070.94 |
Average Inventory |
— | — | 416.65 | 519.67 | 725.87 |
Average Assets |
— | 2,720.57 | 5,486.93 | 5,729.43 | 6,169.73 |
Average Common Equity |
— | — | 670.09 | 1,116.63 | 1,761.50 |
Columns are period end dates